SHARE
COPY LINK

HEALTH

EU health agency urges member states to prepare for more mpox cases

Although the risk for the general population in the EU and EEA is currently considered low, the European Union health agency urged its member states to get ready for more cases of a deadly strain of mpox.

EU health agency urges member states to prepare for more mpox cases
A file photo taken in 2022 shows a patient showing his hand with a sore caused by an infection of the monkeypox virus, in the isolation area for monkeypox patients at the Arzobispo Loayza hospital, in Lima, Peru. Photo: Ernesto Benavides/AFP

In a risk assessment, the European Centre for Disease Prevention and Control (ECDC) said the overall risk for the general population in the EU and European Economic Area (EAA) – 30 countries altogether – remained “low”.

However, it “recommends that public health authorities in the EU/EEA maintain high levels of preparedness planning and awareness-raising activities to enable rapid detection and response”.

The Stockholm-based health body said more imported cases to Europe were “highly likely”.

“Due to the close links between Europe and Africa, we must be prepared for more imported clade I cases,” ECDC director Pamela Rendi-Wagner said in a statement.

The World Health Organization (WHO) this week declared the rapid spread of the new, more dangerous mpox strain, dubbed Clade 1b, a public health emergency of international concern – the highest alarm the UN agency can sound.

The virus has swept through the Democratic Republic of Congo, killing 548 people so far this year, the country’s government said.

Sweden and Pakistan have this week reported the first cases of the virus outside of Africa, with the WHO warning further imported cases of the new strain in Europe were likely.

In an updated risk assessment, the ECDC said that the “overall risk for the EU/EEA general population is currently assessed as low, based on a very low likelihood and a low impact”.

However, it added in the statement that the likelihood of infection for people from Europe “travelling to affected areas who have close contact with affected communities is high”.

“Additionally, there is a moderate risk for close contacts of possible or confirmed imported cases” to Europe.

The infectious disease is caused by a virus transmitted to humans by animals but can also spread human-to-human through close physical contact.

It causes fever, muscular aches and large boil-like skin lesions.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.
For members

HEALTH

Who should get vaccinated against mpox in Austria?

Mpox is expected to spread further, and the WHO has declared a "public health emergency". Who in Austria is advised to get vaccinated against it?

Who should get vaccinated against mpox in Austria?

Recently, the World Health Organisation (WHO) warned that Europe is likely to experience more imported cases of the new, more dangerous strain of mpox.

WHO has asked vaccine manufacturers to increase production due to the outbreak, which started in Africa and has now spread to other parts of the world.

 
The request for more vaccines started after the recent discovery of a more dangerous virus strain called ‘1b,’ which was identified in Sweden and Pakistan.

The situation is not new; there was also a major mpox outbreak in 2022, which led to around 200 deaths. However, the recent discovery of a more dangerous strain, along with rising cases and the virus spreading further, has led the WHO to declare a “public health emergency of international concern.” 

What is mpox?

Mpox, or Affenpocken in German, is an infectious viral disease. It is caused by a virus initially spread to humans by animals, but it can also be transmitted between people through direct contact.

Common symptoms include muscular aches and pains, large lesions and boils, and fever.

Mpox was initially discovered in monkeys in a Danish laboratory in 1958. The first human case was identified in a child in the Democratic Republic of the Congo in 1970.

READ MORE: Europe warned to prepare for mpox as Pakistan reports first case

Who should get vaccinated in Austria?

The National Vaccination Committee (NIG) in Austria currently only recommends vaccination for specific risk groups, such as the following: 

  • Individuals with high-risk behaviour (e.g., those with frequent changing sexual contacts, particularly men with same-sex partners)
  • Staff in specialised laboratories (e.g., those handling samples from individuals infected with mpox or those working with the virus itself)
  • Healthcare workers with very high exposure risk (e.g., those working in designated departments, outpatient clinics, or organisations for diagnosing and treating mpox infections).

Additionally, vaccination can also be considered for travellers who have extensive and prolonged contact with local populations, such as employees of aid organisations in affected countries.

Where can you get the vaccine?

The vaccine is still not available on the open market in Austria and is only offered free of charge at selected vaccination centres in the federal states.

You can check the offers in your state HERE.

How many doses are needed?

The recommended vaccination schedule is currently two doses with an interval of at least 28 days. 

However, if someone is already infected with the virus, a single dose is recommended, and it should be administered within four days of the first close contact.

If a person already has symptoms, the vaccine is not recommended.

READ ALSO: WHO warns more mpox expected in Europe over the coming days or weeks

SHOW COMMENTS